Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2012 1
2014 1
2015 1
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
PET/MRI for Staging the Axilla in Breast Cancer: Current Evidence and the Rationale for SNB vs. PET/MRI Trials.
Di Micco R, Santurro L, Gasparri ML, Zuber V, Cisternino G, Baleri S, Morgante M, Rotmensz N, Canevari C, Gallivanone F, Scifo P, Savi A, Magnani P, Neri I, Ferjani N, Venturini E, Losio C, Sassi I, Bianchini G, Panizza P, Gianolli L, Gentilini OD. Di Micco R, et al. Among authors: magnani p. Cancers (Basel). 2021 Jul 16;13(14):3571. doi: 10.3390/cancers13143571. Cancers (Basel). 2021. PMID: 34298781 Free PMC article. Review.
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy?
Marino R, Ratti F, Della Corte A, Santangelo D, Clocchiatti L, Canevari C, Magnani P, Pedica F, Casadei-Gardini A, De Cobelli F, Aldrighetti L. Marino R, et al. Among authors: magnani p. Cancers (Basel). 2023 Sep 1;15(17):4363. doi: 10.3390/cancers15174363. Cancers (Basel). 2023. PMID: 37686638 Free PMC article.
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data.
Mapelli P, Ghezzo S, Samanes Gajate AM, Preza E, Palmisano A, Cucchiara V, Brembilla G, Bezzi C, Rigamonti R, Magnani P, Toninelli E, Bettinardi V, Suardi N, Gianolli L, Scifo P, Briganti A, De Cobelli F, Esposito A, Picchio M. Mapelli P, et al. Among authors: magnani p. Cancers (Basel). 2022 Jan 11;14(2):334. doi: 10.3390/cancers14020334. Cancers (Basel). 2022. PMID: 35053499 Free PMC article.
Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients.
Mapelli P, Ghezzo S, Samanes Gajate AM, Preza E, Brembilla G, Cucchiara V, Ahmed N, Bezzi C, Presotto L, Bettinardi V, Savi A, Magnani P, Menichini R, Coliva A, Neri I, Di Gaeta E, Gianolli L, Freschi M, Briganti A, De Cobelli F, Scifo P, Picchio M. Mapelli P, et al. Among authors: magnani p. Diagnostics (Basel). 2021 Nov 9;11(11):2068. doi: 10.3390/diagnostics11112068. Diagnostics (Basel). 2021. PMID: 34829417 Free PMC article.
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors.
Mapelli P, Bezzi C, Muffatti F, Ghezzo S, Baldassi F, Schiavo Lena M, Andreasi V, Canevari C, Magnani P, De Cobelli F, Gianolli L, Partelli S, Falconi M, Picchio M. Mapelli P, et al. Among authors: magnani p. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2818-2829. doi: 10.1007/s00259-023-06210-7. Epub 2023 Apr 3. Eur J Nucl Med Mol Imaging. 2023. PMID: 37010579
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours.
Mapelli P, Bezzi C, Muffatti F, Ghezzo S, Canevari C, Magnani P, Schiavo Lena M, Battistella A, Scifo P, Andreasi V, Partelli S, Chiti A, Falconi M, Picchio M. Mapelli P, et al. Among authors: magnani p. Eur J Nucl Med Mol Imaging. 2024 May 2. doi: 10.1007/s00259-024-06730-w. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38696129